Integrated Oncology (United States)

Recent papers from Integrated Oncology (United States)

1. Study protocol of a prospective, non-interventional cohort study evaluating the benefits of transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma receiving first-line atezolizumab plus bevacizumab (NISTIPS TRITICC-4, IKF092)Future Oncology · 2026
2. Safety and immunogenicity of a first-generation modified vaccinia virus Ankara-vectored SARS-CoV-2 vaccine candidate with mRNA-based booster vaccination: A phase 1 trialHuman Vaccines & Immunotherapeutics · 2026
3. [18F]FDG PET/CT-Derived Metabolic Characteristics and Tumour-Infiltrating Lymphocytes for Predicting Axillary Response to Neoadjuvant Chemo-(Immuno)Therapy in Clinically Node-Positive Breast CancerCancers · 2026
4. Study protocol: a phase II study of trifluridine/tipiracil plus liposomal irinotecan as second-line therapy in advanced biliary tract cancer (TRITICC 2)BMC Cancer · 2026
5. Early integration of palliative care in outpatient nephrology: exploring healthcare professionals’ knowledge, attitudes, and communication practices – an exploratory multi-methods studyBMC Nephrology · 2026
6. Selective dependency of CALR-mutant myeloproliferative neoplasms on TYK2 signalingLeukemia · 2026
7. Myeloperoxidase and anti-MPO IgG synergistically enhance TLR9-mediated immune activation in ANCA-associated vasculitisCell Reports · 2026
8. Rare clinical presentation of invasive pulmonary aspergillosis in patient with early-stage lung cancer: a case reportFrontiers in Medicine · 2026
9. Bridging the gap: a genetically validated avian chorioallantoic membrane platform for investigation of spontaneous circulating tumor cellsMolecular Oncology · 2026
10. Efficacy, safety and circulating tumor cell dynamics in patients treated with Eribulin for HER2-negative advanced breast cancer – results from the phase II DETECT IVb trialBreast Cancer Research and Treatment · 2026
11. Leucine, autoimmune diseases, and circulating mediators shape the causal landscape of lymphoid malignanciesFrontiers in Immunology · 2026
12. Fully automated determination of metabolic tumor volume in Hodgkin lymphomaEJNMMI Physics · 2026
13. Evaluation capacity building in community health using a learning-by-doing approach: project overview and study protocolPublic Health Research & Practice · 2026
14. Describing the emotional change experienced by patients with chronic somatic diseases who took part in a supportive program with complementary therapies: a qualitative studyBMC Complementary Medicine and Therapies · 2026
15. 3D ex vivo platform for high‐throughput immunotherapy screening in relapsed/refractory lymphoma patientsHemaSphere · 2026
16. Validation of the advanced‐stage Hodgkin lymphoma international prognostic index (A‐HIPI) in the GHSG HD21 trialHemaSphere · 2026
17. Hidden Mould in the Air: A Practical Narrative Mini‐Review of Invasive Mould Infection Prevention for High‐Risk Patients and CliniciansMycoses · 2026
18. Evaluating the Prognostic Relevance of Pre-Treatment Epstein–Barr Virus Levels in Non-Endemic Pediatric Nasopharyngeal CarcinomaCancers · 2026
19. Age-associated epigenomic heterogeneity in papillary tumors of the pineal region: a multicenter YoungNOA investigationActa Neuropathologica Communications · 2026
20. Xanthogranulomatous prostatitis mimicking prostate carcinoma: a case report and comprehensive literature reviewFrontiers in Medicine · 2026